We have not found any cost information for this lawyer
Todd R Overman
About Todd
Biography
Todd Overman's practice focuses primarily on advising clients doing business with the Federal Government. In this regard, his practice includes a combination of litigation, mergers and acquistions of government contractor entities, and regulatory advice, with a particular emphasis on small business issues.
Practice Areas
4
Practice Areas
Fees and Rates
Looking for an attorney? Avvo can help.
Search our directory
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Avvo's live chat agents can help coordinate a consultation with a local attorney.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withLicenses
Licensed in District of Columbia for 22 years
State: District of Columbia
Acquired: 2004
No misconduct found
Location
Hogan & Hartson
555 13th Street NW, Washington, DC, 20004
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
Todd R Overman's Reviews
Avvo Review Score
Not Yet Reviewed
Todd R Overman's Lawyer Endorsements
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
Experience
Work Experience
2002 - 2003
Law Clerk, United States Court of Federal Claims
Associations
2005 - Present
American Bar Association, Public Contract Law SectionCo-Chair, Legislative Coordinating Committee
2003 - Present
American Bar AssociationMember
Education
2002
Vanderbilt University Law School
JD - Juris Doctor
1997
Duke University
A.B
Publications
2006
Government Contracts and Grants Update
New Re-certification Requirement for Small Businesses Contracting With the Federal Government
2006
The Procurement Lawyer
Building a Biodefense Industry- One Step at a Time
2005
The Government Contractor
A-76 Does Not Govern In-House Performance of Work Under Expired Contract Pending Resolicitation
2005
Pharmaceutical, Biotech and Medical Device Update
Congress and FDA Move to Expedite Commercialization of Pandemic Influenza Products and Bioterrorism Countermeasures